EUCTR2006-000284-28-DE进行中（未招募）不适用
Einfluss einer Behandlung mit dem HMG-CoA Reduktasehemmer Fluvastatin auf die Erektionsfähigkeit bei Patienten mit kardiovaskulären Risikofaktoren und erektiler Dysfunktion - FluvaED
niversitätsklinikum des Saarlandes0 个研究点开始时间: 2006年3月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •erectile dysfunction due to vascular impairment (peak flow of penile artery <30cm/s)
- •two or more cardiovascular risk factors (even orally treated diabetes in patients with HbA1c <7%)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •impaired liver function
- •acute cardiovascular event
- •current treatment with a statin
- •insuline dependent diabetes mellitus or orally treated diabetes mellitus with HbA1c >=7%
研究者
相似试验
已完成
不适用
Effect of co-administration of HMG-CoA Reductase Inhibitor on the endothelial dysfunction after continuous treatment of nitroglycerin in Japanese volunteers with aldehyde dehydrogenase2 Glu487Lys genotypes: randomized crossover trialangina pectorisJPRN-UMIN000013382Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu Univertisy44
进行中（未招募）
1 期
Effects of HMG-CoA-reductase inhibition (atorvastatin) on renal sodium excretion, renal hemodynamics, tubular function and vasoactive hormones in healthy subjects under diet with normal and high sodium content.EUCTR2006-005143-28-DKMedicinsk Forskning
已完成
不适用
The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 SecretionHydroxymethylglutaryl-CoA Reductase InhibitorsDiabetes Mellitus, Type 2NCT03018444University Hospital, Gentofte, Copenhagen15
已完成
不适用
Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target ValuesHypercholesterolaemiaNCT01483950AstraZeneca800
已完成
3 期
Secondary prevention of HMG-CoA reductase inhibitor against strokeIschemic strokeJPRN-C000000207Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical Sciences3,000